Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients

Muscelli, Elza, Mari, Andrea, Casolaro, Arturo, Camastra, Stefania, Seghieri, Giuseppe, Gastaldelli, Amalia, Holst, Jens J., Ferrannini, Ele·2008·Diabetes

DOI 10.2337/db07-1315

Cited by (409)

Items 101–200 of 409

Beta cell connectivity in pancreatic islets: a type 2 diabetes target?
G. Rutter, D. Hodson · 2015 · Cellular and Molecular Life Sciences
Rye-Based Evening Meals Favorably Affected Glucose Regulation and Appetite Variables at the Following Breakfast; A Randomized Controlled Study in Healthy Subjects
Jonna C. Sandberg, Inger Björck, Anne C. Nilsson · 2016 · PLoS ONE
Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes
Andrea Mari, Andrea Tura, Giovanni Pacini, Alexandra Kautzky‐Willer, Eleuterio Ferrannini · 2008 · Diabetic Medicine
Amino acid transporters in the regulation of insulin secretion and signalling
Kiran Javed, Stephen J. Fairweather · 2019 · Biochemical Society Transactions
Beyond glucose lowering: Glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system
Vergès, B., Bonnard, C., Renard, E. · 2011 · Diabetes & Metabolism
Hyperlipidemia-Induced MicroRNA-155-5p Improves β-Cell Function by TargetingMafb
Mengyu Zhu, Yuanyuan Wei, Claudia Geißler, Kathrin Abschlag, Judit Corbalán-Campos, Michael Hristov, Julia Möllmann, Michael Lehrke, Ela Karshovska, Andreas Schober · 2017 · Diabetes
GLP-1 receptor signaling increases PCSK1 and β cell features in human α cells
Mridusmita Saikia, Marlena M. Holter, Leanne R. Donahue, Isaac S. Lee, Qiaonan C. Zheng, Journey L. Wise, Jenna E. Todero, Daryl J. Phuong, Darline Garibay, Reilly W. Coch et al. · 2021 · JCI Insight
Dietary Effects on Incretin Hormone Secretion
Tongzhi Wu, Christopher Keith Rayner, Karen L. Jones, Michael Horowitz · 2010 · Vitamins and hormones
Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT
Marjan Alssema, Josina M. Rijkelijkhuizen, Jens Juul Holst, Tom Teerlink, Peter G Scheffer, Elisabeth M. W. Eekhoff, Amalia Gastaldelli, Andrea Mari, Leen M. ‘t Hart, Giel Nijpels et al. · 2013 · European Journal of Endocrinology
Altered pattern of the incretin effect as assessed by modelling in individuals with glucose tolerance ranging from normal to diabetic
Andrea Tura, Elza Muscelli, Amalia Gastaldelli, Ele Ferrannini, Andrea Mari · 2014 · Diabetologia
Elevated Postoperative Endogenous GLP-1 Levels Mediate Effects of Roux-en-Y Gastric Bypass on Neural Responsivity to Food Cues
Jennifer S. ten Kulve, Dick J. Veltman, Victor E. A. Gerdes, Liselotte van Bloemendaal, Frederik Barkhof, Carolyn Fiona Deacon, Jens Juul Holst, Madeleine L. Drent, Michaëla Diamant, Richard G. IJzerman · 2017 · Diabetes Care
Chronic Exposure to TNFα Impairs Secretion of Glucagon-Like Peptide-1
Jeffrey Gagnon, Meghan Sauvé, Wen Ting Zhao, Holly M. Stacey, Stuart C. Wiber, Steffen Sebastian Bolz, Patricia Lee Brubaker · 2015 · Endocrinology
Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes
Zhanfang Kang, Yi Deng, Y. Zhou, Rongrong Fan, Juliana C.N. Chan, D. Ross Laybutt, Jude Luzuriaga, Gang Xu · 2012 · Diabetologia
Physiology of the Incretin Hormones, GIP and GLP ‐1—Regulation of Release and Posttranslational Modifications
Jens Juul Holst, Nicolai J. Wewer Albrechtsen, METTE MARIE ROSENKILDE, Carolyn Fiona Deacon · 2019 · Comprehensive physiology
Effects of Sitagliptin on Glycemia, Incretin Hormones, and Antropyloroduodenal Motility in Response to Intraduodenal Glucose Infusion in Healthy Lean and Obese Humans and Patients With Type 2 Diabetes Treated With or Without Metformin
Tongzhi Wu, Jing Ma, Michelle J. Bound, Helen L. Checklin, Carolyn Fiona Deacon, Karen L. Jones, Michael Horowitz, Christopher Keith Rayner · 2014 · Diabetes
Incretin Hormone Secretion Over the Day
Bo Åhrén, Richard David Carr, Carolyn Fiona Deacon · 2010 · Vitamins and hormones
Ingestion of a moderate high‐sucrose diet results in glucose intolerance with reduced liver glucokinase activity and impaired glucagon‐like peptide‐1 secretion
Eriko Sakamoto, Yusuke Seino, Ayako Fukami, Naohiro Mizutani, Shin Tsunekawa, Kota Ishikawa, Hidetada Ogata, Eita Uenishi, Hideki Kamiya, Yoji Hamada et al. · 2012 · Journal of Diabetes Investigation
Improvement in Insulin Sensitivity and Β-Cell Function Following Ileal Interposition with Sleeve Gastrectomy in Type 2 Diabetic Patients: Potential Mechanisms
Aureo Ludovico de Paula, Alessandro R. Stival, Alfredo Halpern, Carolina C.L. DePaula, Andrea Mari, Elza Muscelli, Sérgio Alberto Cunha Vencio, Ele Ferrannini · 2011 · Journal of Gastrointestinal Surgery
Effect of the low- versus high-intensity exercise training on endoplasmic reticulum stress and GLP-1 in adolescents with type 2 diabetes mellitus
Sung Soo Lee, Jae Ho Yoo, Yong Seok So · 2015 · Journal of Physical Therapy Science
Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor
Rinki Murphy, Andrea Tura, P. M. Clark, Jens Juul Holst, Andrea Mari, Andrew Tym Hattersley · 2008 · Diabetologia
Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives
Jensterle, Mojca, Herman, Rok, Janež, Andrej · 2022 · Biomedicines
Proton pump inhibitors as a treatment method for type II diabetes
Ivan N. Mefford, Ekpedeme U. Wade · 2009 · Medical Hypotheses
The regulation of function, growth and survival of GLP-1-producing L-cells
Rune E. Kuhre, Jens Juul Holst, Camilla Krizhanovskii · 2015 · Clinical Science
Restoration of the insulinotropic effect of glucose‐dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase‐4 inhibitors
Kasper Aaboe, S. Akram, Carolyn Fiona Deacon, Jens Juul Holst, Sten Madsbad, Thure Krarup · 2014 · Diabetes Obesity and Metabolism
Incretin Hormones, Obesity and Gut Microbiota
Angelini, Giulia, Russo, Sara, Mingrone, Geltrude · 2024 · Peptides
EJE PRIZE 2018: A gut feeling about glucagon
Knop, Filip K · 2018 · European Journal of Endocrinology
Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus
André Jacques Scheen · 2014 · Clinical Pharmacokinetics
The Rho Guanosine 5′-Triphosphatase, Cell Division Cycle 42, Is Required for Insulin-Induced Actin Remodeling and Glucagon-Like Peptide-1 Secretion in the Intestinal Endocrine L Cell
Gareth E. Lim, Molie Xu, Jane Sun, Tianru Jin, Patricia Lee Brubaker · 2009 · Endocrinology
Effect of weight loss on adipokine levels in obese patients
Catherine Rolland, Hession, John I Broom · 2011 · Diabetes Metabolic Syndrome and Obesity
Is there a place for incretin therapies in obesity and prediabetes?
Jens Juul Holst, Carolyn Fiona Deacon · 2013 · Trends in Endocrinology and Metabolism
The incretin system ABCs in obesity and diabetes – novel therapeutic strategies for weight loss and beyond
A. L. João, Flávio Reis, Rosa Fernandes · 2016 · Obesity Reviews
Effects of high-fat diet and the anti-diabetic drug metformin on circulating GLP-1 and the relative number of intestinal L-cells
Camilla Krizhanovskii, Qimin Zhang, Thomas Nyström, Åke Sjöholm · 2014 · Diabetology & Metabolic Syndrome
Therapies for inter-relating diabetes and obesity – GLP-1 and obesity
Iepsen, Eva W, Torekov, Signe S, Holst, Jens J · 2014 · Expert Opinion on Pharmacotherapy
Incretin secretion in humans is under the influence of cannabinoid receptors
Chee W. Chia, Olga D. Carlson, David D. Liu, Isabel González‐Mariscal, Sara Santa-Cruz Calvo, Josephine Mary Egan · 2017 · American Journal of Physiology-Endocrinology and Metabolism
β-Cell Sensitivity to GLP-1 in Healthy Humans Is Variable and Proportional to Insulin Sensitivity
Benedikt A. Aulinger, Torsten Peter Vahl, Hilary Wilson, Ron L. Prigeon, David A. D’Alessio · 2015 · The Journal of Clinical Endocrinology & Metabolism
Is secretion of glucagon-like peptide-1 reduced in type 2 diabetes mellitus?
Juris Jendrik Meier, Michael Albrecht Nauck · 2008 · Nature Clinical Practice Endocrinology &#38 Metabolism
The Incretin Effect and Secretion in Obese and Lean Women with Polycystic Ovary Syndrome: A Pilot Study
Charalambos Pontikis, Maria P. Yavropoulou, Konstantinos A. Toulis, Kalliopi Kotsa, Kyriakos Kazakos, Aleka Papazisi, Anna Gotzamani-Psarakou, John G. Yovos · 2011 · Journal of Women s Health
Mechanisms of the Incretin Effect in Subjects with Normal Glucose Tolerance and Patients with Type 2 Diabetes
Andrea Mari, Jonatan Ising Bagger, Ele Ferrannini, Jens Juul Holst, Filip Krag Knop, Tina Vilsbøll · 2013 · PLoS ONE
The incretin effect in K orean subjects with normal glucose tolerance or type 2 diabetes
Tae Jung Oh, Min Young Kim, Ji Yon Shin, Jung Chan Lee, Sungwan Kim, Kyong Soo Park, Young Min Cho · 2013 · Clinical Endocrinology
Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus
Jens Juul Holst, Maria A. McGill · 2011 · Clinical Drug Investigation
High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications
Agnese Filippello, Stefania Di Mauro, Alessandra Scamporrino, Roberta Malaguarnera, Sebastiano Alfio Torrisi, Gian Marco Leggio, Antonino Di Pino, Roberto Scicali, Francesco Purrello, Salvatore Piro · 2021 · International Journal of Molecular Sciences
GLP-1 receptor agonists, SGLT-2 inhibitors, and obstructive sleep apnoea: can new allies face an old enemy?
Georgios S. Papaetis · 2023 · Archives of Medical Science - Atherosclerotic Diseases
Peripheral targets in obesity treatment: a comprehensive update
Antonios Chatzigeorgiou, Eleni Kandaraki, Athanasios G. Papavassiliou, Michael Koutsilieris · 2014 · Obesity Reviews
Effects of glucose and meal ingestion on incretin secretion in Japanese subjects with normal glucose tolerance
Shunsuke Yamane, Norio Harada, Akihiro Hamasaki, Atsushi Muraoka, Erina Joo, Kazuyo Suzuki, Daniela Nasteska, Daisuke Tanaka, Masahito Ogura, Shin‐ichi Harashima et al. · 2011 · Journal of Diabetes Investigation
Thirty‐Day Morbidity and Mortality of the Laparoscopic Ileal Interposition Associated with Sleeve Gastrectomy for the Treatment of Type 2 Diabetic Patients with BMI <35: An Analysis of 454 Consecutive Patients
Aureo Ludovico DePaula, Alessandro R. Stival, Alfredo Halpern, Sérgio Alberto Cunha Vencio · 2010 · World Journal of Surgery
Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect – a narrative review
Valéria Bahdur Chueire, Elza Muscelli · 2020 · Archives of Endocrinology and Metabolism
Effect of Glycemia on Plasma Incretins and the Incretin Effect During Oral Glucose Tolerance Test
Salehi, Marzieh, Aulinger, Benedict, D’Alessio, David A. · 2012 · Diabetes
Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity
Giuseppina Opinto, Annalisa Natalicchio, Piero Marchetti · 2013 · Archives of Physiology and Biochemistry
Clinical Approaches to Preserve β-Cell Function in Diabetes
BERNARDO LEO WAJCHENBERG · 2010 · Advances in experimental medicine and biology
Islet Cell Antibody–Positive Versus –Negative Phenotypic Type 2 Diabetes in Youth
Hala Mounir Tfayli, Fida F Bacha, Neslihan Gungor, Silva A Arslanian · 2009 · Diabetes Care
Elevated basal and post-feed glucagon-like peptide 1 (GLP-1) concentrations in the neonatal period
Raja Padidela, Michael Patterson, N Sharief, Mohammed A. Ghatei, Khalid Hussain · 2008 · European Journal of Endocrinology
Plasma gastric inhibitory polypeptide and glucagon-like peptide-1 levels after glucose loading are associated with different factors in Japanese subjects
Norio Harada, Akihiro Hamasaki, Shunsuke Yamane, Atsushi Muraoka, Erina Joo, Kazuyo Fujita, Nobuya Inagaki · 2010 · Journal of Diabetes Investigation
Role of vesicle-associated membrane protein 2 in exocytosis of glucagon-like peptide-1 from the murine intestinal L cell
Samantha K. Li, Dan Yan Zhu, Herbert Y. Gaisano, Patricia Lee Brubaker · 2013 · Diabetologia
Reduction of insulinotropic properties of GLP-1 and GIP after glucocorticoid-induced insulin resistance
Marie Eriksen, David Hebbelstrup Jensen, Siri Tribler, Jens Juul Holst, Sten Madsbad, Thure Krarup · 2015 · Diabetologia
Incretin response in Asian type 2 diabetes: Are Indians different?
A. Singh · 2015 · Indian journal of endocrinology and metabolism
Intestinal transit of a glucose bolus and incretin kinetics: a mathematical model with application to the oral glucose tolerance test.
S. Salinari, A. Bertuzzi, G. Mingrone · 2011 · American Journal of Physiology. Endocrinology and Metabolism
Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus
A. Gupta, Herbert Franz Jelinek, Hayder A. Al-Aubaidy · 2016 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery
Michail Kokkorakis, Angeliki Katsarou, Niki Katsiki, Christos Socrates Mantzoros · 2023 · Metabolism
Glucocorticoids suppress GLP-1 secretion: possible contribution to their diabetogenic effects
Camilla Krizhanovskii, Liselotte Fransson, Petra Wolbert, Henrik Ortsäter · 2015 · Clinical Science
Genomic analysis reveals selection in Chinese native black pig
Yuhua Fu, Cencen Li, Qianzi Tang, Shilin Tian, Long Guo Jin, Jianhai Chen, Mingzhou Li, Changchun Li · 2016 · Scientific Reports
Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential
Michael Einar Røder · 2017 · Therapeutic Advances in Chronic Disease
Obesity may attenuate the HbA1c‐lowering effect of sitagliptin in Japanese type 2 diabetic patients
Yoshiyuki Bando, Hideo Kanehara, Keiko Aoki, Azusa Hisada, Daisyu Toya, Nobuyoshi Tanaka · 2011 · Journal of Diabetes Investigation
The contribution of incretin hormones to the pathogenesis of type 2 diabetes
Juris Jendrik Meier · 2009 · Best Practice & Research Clinical Endocrinology & Metabolism
Phenotyping of type 2 diabetes mellitus at onset on the basis of fasting incretin tone: Results of a two‐step cluster analysis
Marco Calogero Amato, Giuseppe Pizzolanti, Vittoria Torregrossa, Felicia Pantò, Carla Santos de Souza Giordano · 2015 · Journal of Diabetes Investigation
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes
Salvatore Calanna, Roberto Scicali, Antonino Di Pino, Filip Krag Knop, Salvatore Piro, Agata Maria Rabuazzo, Francesco Purrello · 2014 · Acta Diabetologica
Long chain saturated and unsaturated fatty acids exert opposing effects on viability and function of GLP-1-producing cells: Mechanisms of lipotoxicity
Thombare, Ketan, Ntika, Stelia, Wang, Xuan, Krizhanovskii, Camilla · 2017 · PLOS ONE
Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets
Franco B. Folli, Giovanna Finzi, Roberto Manfrini, A. Galli, Francesca Casiraghi, Lucia Centofanti, Cesare Berra, Paolo Fiorina, Alberto M. Davalli, Stefano La Rosa et al. · 2023 · American Journal of Physiology-Endocrinology and Metabolism
New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms
Roberto Bizzotto, Domenico Tricò, Andrea Natali, Amalia Gastaldelli, Elza Muscelli, Ralph A. De Fronzo, Silva A Arslanian, Ele Ferrannini, Andrea Mari · 2021 · Diabetes Care
Glycemic effect of pancreatic preproglucagon in mouse sleeve gastrectomy
Ki‐Suk Kim, Chelsea R. Hutch, Landon Wood, I. Jack Magrisso, Randy J. Seeley, Darleen A. Sandoval · 2019 · JCI Insight
The Role of Incretin Therapy at Different Stages of Diabetes
Simona Cernea · 2011 · The Review of Diabetic Studies
Myeloid-Derived Growth Factor Promotes Intestinal Glucagon-Like Peptide-1 Production in Male Mice With Type 2 Diabetes
Li Wang, Yixiang Li, Bei Guo, Jiajia Zhang, Biao Zhu, Huan Li, Yan Ding, Biying Meng, Hui Zhao, Lin Xiang et al. · 2020 · Endocrinology
GLP-1R activation for the treatment of stroke: Updating and future perspectives
Vladimer Darsalia, David Nathanson, Thomas Nyström, Thomas Klein, Åke Sjöholm, Cesare Patrone · 2014 · Reviews in Endocrine and Metabolic Disorders
Improvement of Glucose Tolerance by Food Factors Having Glucagon-Like Peptide-1 Releasing Activity
Tohru Hira, Aphichat Trakooncharoenvit, Hayate Taguchi, Hiroshi Hara · 2021 · International Journal of Molecular Sciences
Pharmacokinetics and pharmacodynamics of the glucagon-like peptide-1 analog liraglutide in healthy cats
M.J. Hall, Christopher A. Adin, Sofia Borin‐Crivellenti, Adam Joseph Rudinsky, Päivi J. Rajala‐Schultz, Jeffrey Lakritz, Chen Gilor · 2014 · Domestic Animal Endocrinology
Physiology of Glucose Homeostasis and Insulin Therapy in Type 1 and Type 2 Diabetes
Ele Ferrannini · 2012 · Endocrinology and Metabolism Clinics of North America
RD Lawrence Lecture 2008 Targeting GLP‐1 release as a potential strategy for the therapy of Type 2 diabetes
Fiona Mary Gribble · 2008 · Diabetic Medicine
The relationship between sleep and glucagon‐like peptide 1 in patients with abnormal glucose tolerance
Sirimon Reutrakul, Rungtip Sumritsopak, Sunee Saetung, Suwannee Chanprasertyothin, Thunyarat Anothaisintawee · 2017 · Journal of Sleep Research
A Journey in Diabetes: From Clinical Physiology to Novel Therapeutics: The 2020 Banting Medal for Scientific Achievement Lecture
Ele Ferrannini · 2021 · Diabetes
Patient and treatment perspectives: Revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk
Laurence Kennedy, Anne L. Peters · 2009 · Cleveland Clinic Journal of Medicine
Short-term aerobic exercise training improves gut peptide regulation in nonalcoholic fatty liver disease
Emily L. Kullman, Karen R. Kelly, Jacob M. Haus, Ciarán E. Fealy, Amanda R. Scelsi, Mangesh R. Pagadala, Chris A. Flask, Arthur J. McCullough, John P. Kirwan · 2016 · Journal of Applied Physiology
Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release
José de Jesús Garduño‐García, Amalia Gastaldelli, Ralph A. DeFronzo, Raweewan Lertwattanarak, Jens Juul Holst, Nicolas Musi · 2018 · The Journal of Clinical Endocrinology & Metabolism
Metabolic diseases affect male reproduction and induce signatures in gametes that may compromise the offspring health
Sara Pereira, Luís Crisóstomo, Mário Sousa, Pedro Fontes Oliveira, Marco Gouveia Alves · 2020 · Current Zoology
A phase I open-label clinical trial to study drug-drug interactions of Dorzagliatin and Sitagliptin in patients with type 2 diabetes and obesity
Li Chen, Jiayi Zhang, Yu Sun, Yu Zhao, Xiang Liu, Zhiyin Fang, Lingge Feng, Bin He, Quanfei Zou, Gregory J. Tracey · 2023 · Nature Communications
The physiology and pharmacology of incretins in type 2 diabetes mellitus
Jens Juul Holst · 2008 · Diabetes Obesity and Metabolism
Evidence for paracrine/autocrine regulation of GLP-1-producing cells
Camilla Krizhanovskii, Qimin Zhang, Jens Juul Holst, Thomas Nyström, Åke Sjöholm · 2013 · American Journal of Physiology-Cell Physiology
Gastrointestinal capacity, gut hormones and appetite change during rat pregnancy and lactation
Michelle L. Johnson, Margaret Jill Saffrey, Victoria Taylor · 2019 · Reproduction
Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response
Annalisa Natalicchio, Giuseppina Biondi, Nicola Marrano, Rossella Labarbuta, Federica Tortosa, Rosaria Spagnuolo, Rossella D’Oria, Emanuele Carchia, Anna Leonardini, Angelo Cignarelli et al. · 2016 · Endocrinology
Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?
Matthias Ploug Larsen, Signe S. Torekov · 2017 · Journal of Diabetes Research
Plasma Level of Glucagon-like Peptide 1 in Obese Egyptians with Normal and Impaired Glucose Tolerance
Magda Shoukry Hussein, Manal Mohammed Abushady, Safa Refaat, Rasha Youssef Mohammed Ibrahim · 2013 · Archives of Medical Research
Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes
Eleonora Grespan, Toni Giorgino A, Andrea Natali, Ele Ferrannini, Andrea Mari · 2020 · Metabolism
Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus
Francesca Urbano, Agnese Filippello, Antonino Di Pino, Davide Barbagallo, Stefania Di Mauro, Alessandro Pappalardo, Agata Maria Rabuazzo, Michele Purrello, Francesco Purrello, Salvatore Piro · 2016 · American Journal of Physiology-Cell Physiology
Gastrointestinal peptides in eating-related disorders
Kimberly Smith, Timothy H. Moran · 2021 · Physiology & Behavior
The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact?
Aulinger, Benedikt A., Vahl, Torsten P., Prigeon, Ron L., D'Alessio, David A., Elder, Deborah A. · 2016 · American Journal of Physiology-Endocrinology and Metabolism
The Place of GLP-1–Based Therapy in Diabetes Management: Differences Between DPP-4 Inhibitors and GLP-1 Receptor Agonists
Dara L. Eckerle Mize, Marzieh Salehi · 2013 · Current Diabetes Reports
Defective Amplifying Pathway of β-Cell Secretory Response to Glucose in Type 2 Diabetes: Integrated Modeling of In Vitro and In Vivo Evidence
Eleonora Grespan, Toni Giorgino A, Silva A Arslanian, Andrea Natali, Ele Ferrannini, Andrea Mari · 2017 · Diabetes
Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes
Mikkel Christensen, Filip Krag Knop, Tina Vilsbøll, Kasper Aaboe, Jens Juul Holst, Sten Madsbad, Thure Krarup · 2010 · Regulatory Peptides
Atrial Natriuretic Peptide in the High Normal Range Is Associated With Lower Prevalence of Insulin Resistance
Amra Jujić, Peter M. Nilsson, Margaretha Persson, Jens Juul Holst, Signe S. Torekov, Valeriya Lyssenko, Leif Groop, Olle Melander, Martin Magnusson · 2016 · The Journal of Clinical Endocrinology & Metabolism
Antidiabetic Effects of Omega-3 Polyunsaturated Fatty Acids: From Mechanism to Therapeutic Possibilities
Yuko Iwase, Noriyasu Kamei, Mariko Takeda‐Morishita · 2015 · Pharmacology &amp Pharmacy
DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity
Anja Böhm, Robert J. Wagner, Fausto E Machicao, Jens Juul Holst, Baptist Gallwitz, Norbert Stefan, Andreas Fritsche, Hans‐Ulrich Häring, Harald Staiger · 2017 · PLoS ONE
Glucagon-like peptide-1 secretion in women with gestational diabetes mellitus during and after pregnancy.
Cristina Lencioni, Veronica Resi, F Romero, Roberto Lupi, Laura Volpe, Antonio Bertolotto, Alessandra Ghio, Stefano Del Prato, Piero Marchetti, Graziano Di Cianni · 2011 · PubMed